Within the critically needed area of hemorrhagic fever viruses, GeoVax has successfully developed vaccine candidates addressing Ebola Zaire, Ebola Sudan and Marburg, all having demonstrated ...

A WHO report last week, however, did not rule out a risk of regional and international transmission in the near future of the Ebola virus following a new epidemic of this hemorrhagic fever in the ...

Ebola has not been eradicated, however. This deadly virus, which causes severe hemorrhagic fever in humans and has a fatality rate of about 50%, is still at large and could thus still cause a ...

which manifests as a viral hemorrhagic fever. A trial vaccine known as rVSV-ZEBOV, used to vaccinate 3,000 people at risk of ...

Ebola first emerged in 1976 in outbreaks in the Democratic Republic of Congo (then Zaire) and South Sudan (then Sudan), and tracked to bush-meat. Results from virus sequencing of samples from the ...